[AACR] The MYC Inhibitor, OMO-103, Demonstrates Safety and Preliminary Activity Closed
|
Reward30points
|
30
BRCA1-mediated dual regulation of ferroptosis exposes a vulnerability to GPX4 and PARP co-inhibition in BRCA1-deficient cancers
30
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models
20
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
20
Facts and Hopes in Using Omics to Advance Combined Immunotherapy Strategies
20
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges
